Diferencias en el metabolismo mineral óseo hiperparatiroidismo primario normocalcémico respecto al hiperparatiroidismo primario clásico / Differences in bone mineral metabolism normocalcemicprimary hyperparathyroidism with respect to classicalprimary hyperparathyroidism

OBJETIVO: El hiperparatiroidismo primario normocalcémico es una variedad menos conocida del hiperparatiroidismo primario clásico. Presentamos en este estudio sus manifestaciones clínicas y los datos relacionados con el metabolismo mineral óseo, tanto desde el punto de vista analítico como densitométrico, comparando los mismos con un grupo de pacientes afectos de hiperparatiroidismo primario clásico, con hipercalcemia. MATERIAL Y MÉTODOS: Estudio de casos y controles donde consideramos caso a pacientes afectos de hiperparatiroidismo primario normocalcémico (n=25) y control (n=25) a pacientes con hiperpartiroidismo primario con hipercalcemia (hiperparatiroidismo primario clásico). Se les efectuó una evaluación clínica completa con recogida de datos clínicos y realizándose determinaciones analíticas en sangre y orina de 24h, así como la estimación de la densidad mineral ósea y el trabecular bone score por densitometría (absorciometría radiológica dual, DXA) y los parámetros ultrasonográficos en el calcáneo. RESULTADOS: En el estudio clínico, los pacientes afectos de hiperparatiroidismo primario clásico solo muestran una mayor prevalencia de urolitiasis (OR: 9,333; IC 95%: 1,50-82,7) en comparación con los pacientes que sufren un hiperparatiroidismo primario normocalcémico. En todos los demás parámetros clínicos, analíticos, densitométricos y ultrasonográficos, no se aprecian diferencias estadísticamente significativas entre ambos grupos. CONCLUSIONES: Con la excepción de los niveles séricos de calcio y la prevalencia de urolitiasis, el hiperparatiroidismo normocalcémico cursa de manera indistinguible del hiperparatiroidismo clásico

OBJECTIVE: Normocalcemic primary hyperparathyroidism is a less known variety of classical primary hyperparathyroidism. In this paper, we present its clinical expression and data related to bone mineral metabolism, both analytically and densitometrically, comparing them with a group of patients with classic primary hyperparathyroidism, with hypercalcemia. MATERIAL AND METHODS: Study of cases and controls where we consider case of patients with normocalcemic primary hyperparathyroidism (n=25) and control (n=25) of patients with primary hyperpartyroidism with hypercalcemia (classical primary hyperparathyroidism). A complete clinical assessment was carried out with clinical data collection and24h blood and urine analytical determinations were performed, as well as estimating bone mineral density and trabecular bone score by densitometry (dual x‐ray absorptiometry, DXA) and ultrasound parameters in the calcaneus. RESULTS: In this clinical study, patients with classic primary hyperparathyroidism only show a higher prevalence of urolithiasis (OR: 9.333; 95% CI: 1.50‐82.7) compared to patients suffering from a normocalcemic primary hyperparathy‐roidism. In all other clinical, analytical, densitometric and ultrasonographic parameters, there are no statistically significant differences between the two groups. CONCLUSIONS: Apart from serum calcium levels and the prevalence of urolithiasis, normocalcemic hyperparathyroidism is indistinguishable from classical hyperparathyroidism

Bcl-2 expression in a diabetic embryopathy model in presence of polyamines.

The frequency of congenital malformations is 3-5 times higher in mothers with pregestational diabetes mellitus than in general population. Apparently, this problem is due to change in the expression of apoptotic and antiapoptotic genes induced by the oxidative stress derived from the diabetes/hyperglycemia. One of these genes is Bcl-2, which is associated with the control and inhibition of apoptosis. The purpose of the present work was to study the effect of polyamine addition over expression of Bcl-2 gene in a model of diabetic embryopathy. For this, gestational day 10.5 (GD10.5) rat embryos were incubated at 37°C for 24 h in control medium, medium with high glucose, or medium with high glucose and supplemented with spermidine or spermine. Post-cultured embryos were harvested and observed to obtain morphological scores; some of them were subjected to molecular biology studies: DNA isolation plus conventional PCR or RNA isolation plus RT-PCR; other embryos were fixed with paraformaldehyde and used for immunohistochemical detection of Bcl-2 protein. Although Bcl-2 mRNA was similarly expressed in all rat embryo treatments, Bcl-2 protein was found only in control-incubated embryos. In conclusion, it seems that the inhibition of Bcl-2 gene expression induced by glucose was not reversed by polyamines.

Uso inadecuado de inhibidores de la bomba de protones y riesgo de fractura por fragilidad. Estudio preliminar / Inappropriate use of proton-pump inhibitors and fragility fracture risk. A preliminary study

Introducción: Los inhibidores de la bomba de protones (IBP) son fármacos ampliamente utilizados, si bien esto conlleva a un sobreuso que no es acorde con las indicaciones aceptadas en España y en el resto de Europa. Por otro lado, algunos autores han establecido una posible implicación de los IBP en el riesgo de fractura. Con este trabajo hemos pretendido efectuar una primera aproximación al conocimiento del consumo de IBP en nuestro medio y analizar para qué indicación son prescritos, a la vez que estudiar su posible asociación con un mayor riesgo de fractura por fragilidad entre sus consumidores. Material y método: Estudio observacional, transversal, abierto, descriptivo, en el que se entrevistó aleatoriamente a un número de pacientes que fueron atendidos en diferentes ámbitos sanitarios: consultas externas hospitalarias, servicios de urgencias, consulta de Atención Primaria y pacientes ingresados en planta hospitalaria. Resultados: De los 411 pacientes entrevistados, el 54% de los pacientes recibían IBP, y cuya edad media era de 63,3 años, frente al 46% que no los tomaban y que eran más jóvenes, con una edad media de 50,9 años. La distribución por sexos fue similar. La principal razón de utilizar el IBP era como “protector gástrico”, en el 39,8% de los pacientes, indicación no existente en la ficha técnica de este grupo de fármacos. Los consumidores de IBP tenían una mayor prevalencia de todas las fracturas por fragilidad. Conclusiones: Más de la mitad de la población encuestada consume IBP, y de ella cerca del 40% sin una indicación médica correcta. Por esto, unido a la mayor prevalencia de fracturas por fragilidad que presentan -que nos hace pensar en un posible mayor riesgo de fractura entre sus usuarios- consideramos la necesidad de un uso más racional de estos fármacos. Estas conclusiones son preliminares pero, a la vista de estos resultados, creemos que puede ser interesante realizar más estudios dirigidos a comprobar de manera más firme la relación entre los IBP y el riesgo de fractura osteoporótica (AU)

Introduction: Proton-pump inhibitors (PPIs) are widely used drugs, though it should be noted that excessive use is not in line with the accepted indications in Spain and throughout Europe. Furthermore, some authors have established a possible PPI link to the risk of fracture. In this paper, we make an initial approach to knowledge into PPI consumption and analyze what indication is prescribed. We also studied the drugs’ possible association with increased risk of fragility fracture in users. Material and method: An observational, transversal, open and descriptive study in which a number of randomly-chosen patients were interviewed. These patients had been treated in outpatient, emergency and primary care centers. Some had also been treated in hospital wards. Results: Of the 411 patients interviewed, 54% received PPIs. The average age was 63.3 years, compared with 46% that did not take them and who were younger presenting a mean age of 50.9 years. Gender distribution was similar. PPIs were mainly used as a “gastric protector”, in 39.8% of the patients, with no indication appearing in the technical specifications for this group of drugs. Consumers of PPIs presented a higher prevalence of all fragility fractures. Conclusions: More than half of the population surveyed consumed PPI. Of this group, about 40% did so without proper medical advice. Therefore, in addition to the higher prevalence of fragility fractures that suggest a possible increased risk of fracture among its users, we consider the need for a more rational use of these drugs. These preliminary findings point to a need for further studies to confirm the relationship between PPIs and the risk of osteoporotic fracture (AU)

Melorreostosis: presentación de un caso clínico / Melorheostosis: presentation of a clinical case

La melorreostosis es una forma de hiperostosis que afecta tanto al tejido óseo como a las partes blandas adyacentes. Su incidencia es variable aunque es mayor en la segunda y tercera décadas de la vida debido al carácter lentamente progresivo de la enfermedad. Generalmente cursa con dolor que puede llegar a provocar una limitación funcional importante. Para su diagnóstico nos podemos apoyar en la imagen radiológica característica que semeja "cera fundida deslizándose por el lateral de una vela". Se presenta un caso de melorreostosis con hallazgos clínicos y radiológicos característicos. El paciente había sido diagnosticado previamente de enfermedad ósea de Paget, por lo que planteamos el diagnóstico diferencial de esta patología (AU)

Melorheostosis is a form of hyperostosis which affects both bone and the adjacent soft tissues. Its incidence is variable, although it is higher in the second and third decades of life due to the slowly progressive nature of the disease. It generally presents with pain which may cause significant functional limitation. We may be assisted in its diagnosis by its characteristic radiological image which resembles "wax melting down the side of a candle". A case of melorheostosis is presented with clinical findings and radiological characteristics. The patient had previously been diagnosed with Paget’s disease of bone, so we proposed a differential diagnosis of this pathology (AU)

¿Son válidos los criterios quirúrgicos actuales del hiperparatiroidismo primario asintomático? / Are the current surgical criteria for asymptomatic primary hyperparathyroidism valid?

El HPTP es una patología muy frecuente que a menudo cursa de manera asintomática. Siendo la intervención quirúrgica el único tratamiento curativo de la enfermedad, existen unos criterios de indicación de cirugía que no siempre se ajustan a la realidad del paciente, pues se basan en la existencia de complicaciones clínicas (osteoporosis, insuficiencia renal, urolitiasis, fracturas por fragilidad). Presentamos el caso clínico de una paciente que no cumplía ninguno de los requisitos para ser intervenida quirúrgicamente según los documentos de posición, y que fue operada tras demostrarse la existencia de un deterioro de la estructura trabecular ósea, determinada por la técnica TBS (trabecular bone score), y localizarse el adenoma por gammagrafía. Se discute la posible utilidad de estas técnicas, no observadas en los documentos de posición, como complemento de la decisión de cirugía (AU)

HPTP is a very frequent pathology which often develops asymptomatically. Surgical intervention being the only curative treatment for this disease there are some criteria for the indication of surgery, but these do not always fit the reality of the patient since they are based on clinical complications (osteoporosis, renal insufficiency, urolithiasis, fragility fractures). We present the clinical case of a patient who did not meet any of the requirements for having surgical intervention according to the position documents, and who was operated on after the existence was shown of a deterioration of the trabecular bone structure, determined by the TBS (trabecular bone score) technique, and located in the adenoma using gammagraphy. The possible use of these techniques, not seen in the position documents, to complement the decision regarding surgery, is discusse (AU)

Tratamiento de las osteoporosis / No disponible

No disponible

Automated peritoneal dialysis as a lifesaving therapy in an emergency room: report of four cases.

The present article describes four cases of patients with chronic kidney disease who arrived at the emergency room in critical condition, needing acute dialysis for severe hyperkalemia and metabolic acidosis. These four patients were treated acutely with automated peritoneal dialysis (APD) using a Tenckhoff catheter placed percutaneously at the bedside in the emergency room. All patients were discharged in good condition and with APD as their chronic renal replacement therapy (RRT). APD is a RRT, that may be considered a frontline acute therapy option for renal failure patients in an emergency room. Coordinated teamwork between emergency and nephrology medical and nursing staff is the key to a successful outcome in these life threatening situations.

[Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine]. / Guía de prevención y tratamiento de la osteoporosis inducida por glucocorticoides de la Sociedad Española de Medicina Interna.

Our objective has been to elaborate an updated Clinical Guide of the Spanish Society of Internal Medicine (SEMI) for the prevention and treatment of glucocorticoids-induced osteoporosis (GIO), identifying and measuring the grade of evidence that supports the given recommendations. For this, we reviewed studies performed on pathophysiology, diagnosis, prevention and treatment of GIO and after analyzing them we elaborated the present recommendations. This was done after a pre-specified and reproducible process that included an accepted model for the evaluation, and the reference of the evidence that supported it. Once the Scientific Committee elaborated the draft of the Clinical Guide, it was reviewed by all the members of the Working Group on Osteoporosis of the SEMI, and by an External Committee who included experts of many different specialities. Pathophysiology of GIO is complex and yet unknown. Bone effects of glucocorticoids are determined by multiple factors although accumulated doses seems to be the most important one. The best method to diagnose GIO is Dual X-Ray Absorptiometry (DXA), although WHO criteria defined for the diagnosis of postmenopausal osteoporosis are not applicable in GIO. The presence of a T-score lower than -1.5 Tscore indicates the necessity of treatment in any patient who receives or is going to receive more than 3 months treatment with glucocorticoids at a dose higher than 2.5 mg/day (in postmenopausal women) and 5 mg/day (in premenopausal women and men). DXA is also useful to follow up the patients, who can be done annually. Treatment must be prescribed to any patient who is receiving glucocorticoids or is going to receive them at doses higher than 7.5 mg/day for more than 3 months and 5 mg/day if the patient is a postmenopausal woman or has suffered from previous fragility fractures. Risedronate and alendronate are the drugs of election, always together with calcium and vitamin D supplements and general measurements usually prescribed in the treatment of osteoporosis. In very ill patients, parathyroid hormone can be used. The treatment for GIO should be maintained while glucocorticoid therapy is used.

Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions.

Cervical cancer (CC) is the most common in Mexican female population. The human papillomavirus (HPV) 16 and 18 frequencies in worldwide may be different due to geographical distribution. We analyzed the prevalence of HPV types and determinated their association in cervical lesion in a Mexican population. One hundred fifty-nine normal cervical smears, 95 low-grade squamous intraepithelial lesions (LGSIL), 59 high-grade squamous intraepithelial lesions (HGSIL), and 108 CC samples of the patients were collected. HPV types were determined by sequencing. We detected 11 high-risk types, four low-risk types, three not determinated, and two probably high risk. HPV were present in 12%, 57%, 88%, and 92% from normal, LGSIL, HGSIL, and CC samples, respectively. HPV 16 was the most common in all cervical lesions (71.6% in CC). HPV 58 was present in 18.6% of HGSIL, and the HPV 18 in 4.6% of CC. The 76% of all detected viruses belong to A9 species branch. Control women showed high percentage of HPV high-risk infection, suggesting that this is a high-risk group. High frequency of HPV 16 compared with a low incidence of HPV 18 was observed. HPV 58 is frequently detected in HGSIL but low frequency is found in CC. These findings might be considered for HPV screening.

Efecto de la administración crónica de estrógenos en varones transexuales sobre el metabolismo mineral óseo. Influencia del polimorfismo del receptor de la vitamina D / Effect of chronic administration of estrogens on bone mineral metabolism in transsexual males . Influence of Vitamin D receptor polymorphism

Fundamento. No se conoce cuál es el efecto que produce la administración crónica de estrógenos en el metabolismo mineral óseo del varón. Por otra parte, en algunos estudios se ha informado que un determinado polimorfismo del receptor de la vitamina D podría condicionar una mayor densidad mineral ósea. Estos estudios a menudo han mostrado resultados contradictorios y la mayor parte de ellos se han efectuado en mujeres. Por todo ello hemos realizado este trabajo en un grupo de varones transexuales que habían recibido estrógenos durante un mínimo de tres años, con el fin de analizar si un determinado polimorfismo del receptor de la vitamina D condiciona en ellos diferencias en el metabolismo mineral óseo. Método. Estudio transversal de casos y controles. Hemos estudiado marcadores bioquímicos de remodelado óseo, la densidad mineral ósea, así como varias hormonas sexuales y calciotropas. Resultados. Comparados con los controles, los transexuales mostraron menores valores de testosterona libre en sangre y mayores valores de estradiol y de densidad mineral ósea, tanto en la columna lumbar como en la cadera. La bioquímica general, los marcadores bioquímicos de remodelado óseo y las hormonas calciotropas no mostraron diferencias estadísticamente significativas entre ambos grupos. El polimorfismo del receptor de la vitamina D no condicionó ninguna diferencia en estas variables, ni en los transexuales ni en los controles. Conclusiones. No hemos encontrado asociación alguna entre el fenotipo transexual y la distribución del polimorfismo del receptor de la vitamina D. La administración crónica de estrógenos en el varón produce un aumento en los niveles de estradiol sérico, y un incremento en la densidad mineral ósea tanto en la columna lumbar como en la cadera, que no guarda relación con la presencia de un determinado polimorfismo del receptor de la Vitamina D, a pesar de existir una marcada reducción en la concentración de testosterona libre (AU)

Osteogénesis imperfecta. Estudio evolutivo y control a largo plazo de las fracturas / Osteogenesis imperfecta. Evolutive study and long-term control of fractures

Presentamos en esta nota clínica el caso de un paciente afecto de osteogénesis imperfecta tipo III, en el que se aprecian las características manifestaciones de esta forma clínica, con una evolución prolongada en el tiempo y con las típicas fracturas múltiples y recurrentes, destacando las llamativas complicaciones que fueron apareciendo; todo ello acompañado de una amplia documentación gráfica (AU)

Efecto de la ingesta moderada de alcohol en el metabolismo óseo y la prevalencia de osteoporosis en la mujer postmenopáusica / Effect a moderate alcohol comsumption on bone mineral metabolism in postmenopausal women

Fundamento. Existen trabajos con resultados discrepantes sobre la repercusión que la ingesta moderada de alcohol puede tener sobre el metabolismo mineral óseo. Por ello, en el presente estudio analizamos el efecto que esta sustancia produce sobre la densidad mineral ósea, los marcadores bioquímicos de remodelamiento óseo, algunas hormonas calciotropas y la prevalencia de fracturas, en una población de mujeres postmenopáusicas. Método. A 974 mujeres postmenopáusicas estudiadas consecutivamente se les realizó un cuestionario dirigido y se determinó la densidad mineral ósea por absorciometría dual con rayos X (DEXA) en columna lumbar y extremidad proximal de cadera y por tomografía cuantitativa computarizada (TCC) en columna lumbar. Asimismo se estudiaron los marcadores bioquímicos de remodelado óseo y se recogió la existencia de fracturas osteoporóticas, tanto por la historia clínica (Colles, cadera) como por radiografía (Rx) de columna dorso-lumbar (vertebrales).Resultados. Las mujeres que ingieren cantidades moderadas de alcohol tienen valores más elevados de densidad mineral ósea en la columna lumbar, tanto por DEXA (0,890 ñ 0,158 g/cm2 frente a 0,856 ñ 0,147 g/cm2) como por TCC (122,1 ñ 46,3 mg/cc frente a 113,1 ñ 48 mg/cc), p < 0,05 en todos los casos.En la cadera se obtuvo el mismo resultado en el cuello femoral y trocánter, pero no fue así en otras áreas, como el intertrocánter, el total de cadera y el triángulo de Ward. Cuando se efectuaron las comparaciones de los Z-score las diferencias fueron estadísticamente significativas en columna lumbar por TCC y en cuello femoral por DEXA, pero no en columna lumbar por DEXA. La prevalencia de valores densitométricos de normalidad, osteopenia y osteoporosis fue similar entre las mujeres que ingerían cantidades moderadas de alcohol y las abstemias y la prevalencia de fracturas fue similar en ambos grupos (odds ratio: 0,858; 0,606; 1,331).Conclusión. La ingesta moderada de alcohol produce un pequeño, pero significativo, incremento en la densidad mineral ósea de la mujer postmenopáusica. No existe una menor frecuencia de osteoporosis y tampoco una reducción en la prevalencia de fracturas. Por ello creemos que no puede aceptarse que el alcohol, ingerido en cantidades moderadas, tenga un efecto protector sobre el hueso (AU)

Osteoporosis por inmovilización voluntaria / Osteoporosis by voluntary immobilization

De forma clásica, múltiples patologías físicas se han considerado como causas de osteoporosis secundaria, entre ellas la inmovilización prolongada por enfermedades neurológicas paralizantes. Sin embargo, los desórdenes psíquicos causantes de osteoporosis son escasos y poco documentados, a excepción, lógicamente, de la anorexia nerviosa. Presentamos un caso de depresión mayor que llevó al paciente a un encamamiento voluntario durante más de 3 años; éste a su vez le ocasionó la aparición de una osteoporosis intensa, con producción de múltiples fracturas. Si bien no se trata de una etiología directa, la depresión debe considerarse, por la escasa actividad física que suele acompañarla (incluso en grado extremo, como en el caso presentado), como una posible causa de osteoporosis (AU)

[Scintigraphy with 99mTc-MIBI for assessment of tumor response to preoperative chemotherapy in patients with osteosarcoma]. / Centelleografía con 99mTc MIBI para valorar la respuesta tumoral a la quimioterapia preoperatoria en pacientes con osteosarcoma.

In osteogenic sarcoma an increase in patient survival has been observed due to improvement of diagnostic and treatment methods. The objective of the investigation was to determine the usefulness of scintigraphy with 99mTc-MIBI in comparison to clinical revaluation, in order to assess tumor response (sarcoma) to chemotherapy previous to surgery. Patients with histopathological osteogenic sarcoma that received chemotherapy were included, clinical and scintigraphy response was assessed previous to the surgery. The gold standard for comparison was the degree necrosis histopathological analysis of the surgical specimen with measurement. Twelve patients met the inclusion criteria. A was observed a higher correlation between the 99mTc-MIBI and the histopathology. vs. clinical evaluation (0.89 vs. 0.59 respectively). Likewise the sensitivity (Se) and specificity (Sp) were superior (Se and Sp = 100% vs. Se 66.6% and Sp 75%) when therapeutically responses good and null were compared. We may conclude that scintigraphy with 99mTc-MIBI used to asses the response to presurgery chemotherapy in patients with osteogenic sarcoma, together with the clinical assessment, help the physician to make therapeutically decisions with more objectivity and certainly.

H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix.

BACKGROUND: The invasive and metastatic potential of malignant cells results from complex interactions of numerous factors not yet fully understood. Genomic alterations such as ras overexpression and nm23-H1 inhibition have been found to be frequently associated with increased invasiveness in various cancers. On the other hand, secretion of different proteinases are necessary for malignant cells to traverse a network of matrix macromolecules, but the relationship between the genomic alterations and the proteolytic phenotype is still unclear. Our aim was to investigate whether the appearance of the proteolytic phenotype had any correlation with the expression of H-ras and nm23-H1 genes in carcinoma of the uterine cervix. METHODS: Twenty-five samples from patients with carcinoma of the uterine cervix at different clinical stages were studied. Cathepsin B1, plasminogen activator, and collagenase activity were assessed in tissue cytosols using specific synthetic oligopeptides as substrates. The expression of H-ras and nm23-H1 was investigated by means of immunohistochemistry and in situ hybridization. RESULTS: Our results showed that cathepsin B1 was the most consistently elevated proteinase, demonstrating a linear correlation with clinical staging. H-ras expression was found elevated in 40% of the cases. Nm23-H1 protein immunoreactivity was positive in 40% of the cases. No correlation was found among H-ras, cathepsin B1 activity, and survival rate. Among cases with high cysteine proteinase activity, a different clinical behavior depending on the expression of Nm23-H1 was observed. The cases with Nm23-H1 protein had a markedly better survival rate than those lacking this protein. In contrast, the absence of Nm23-H1 in association with high cathepsin B1 activity was a clear indicator of a poor prognosis. CONCLUSIONS: These findings suggest a complex interaction between the proteolytic phenotype and the expression of H-ras and nm23-H1 genes in carcinoma of the cervix that influences the clinical behavior of the tumor.

[Characteristics of medical care related to autopsy authorization in a pediatric hospital]. / Características de la atención médica relacionadas con la autorización de autopsias en un hospital pediátrico.

OBJECTIVE: To identify some differences of patients and medical characteristics related to autopsy authorization. DESIGN: Observational, cross-sectional study. SETTING: Third-level medical care in a pediatric hospital. METHODS: A specific mortality questionnaire was analyzed by members of the mortality staff, because they reviewed deaths which occurred between January 1994 and December 1995. Descriptive statistic and non-parametric tests (X2) were calculated to analyze data. RESULTS: A total of 408 deaths were evaluated, in which 116 autopsies were done (28.4%). Children less than 18 months of age had the highest frequencies of autopsies (33.3%-30.7%). The patients referred by other units and the autopsy application done by a medical resident, had the highest frequencies of acceptance (32.5%, 35.3%, p < 0.05). The detection of diagnostic and therapeutic problems were related with high frequencies of autopsies (37.7%, 36% p < 0.05). CONCLUSIONS: The results show us that some medical care factors are related to higher frequencies of autopsies. It is important to consider them in order to increase the capacity of teaching that a postmortem study has.

Factors associated with non-use of Pap test. A population survey.

BACKGROUND: Cervical cancer is the most important cancer in Mexican women. Early detection is possible by means of the Papanicolaou (Pap) test; however, the coverage in Mexico is low. METHODS: A cross-sectional survey was carried out in a representative sample of women from the Tlalpan area of Mexico City. Social, reproductive and health care factors associated with the lack of use of the Pap test with respect to adequate use and misuse were identified. Both bivariate and logistic regression analyses were used for the adjustment of variables. RESULTS: Of 1,215 women studied, 22.5% had never had a Pap smear, 42% had misused the test (< 90% of triennial performance), and 35.5% had adequately used the test (> or = 90% of triennial performance). The main factors related to the lack of use were the following: not knowing about the Pap test (ORa = 35.16, 95% C.I. = 17.4-70.9); having fewer than 6 years of education (ORa = 4.5, 95% C.I. = 2.5-8.4); women younger than 30 years of age (ORa = 3.4 95% C.I. = 2.3-5.1); use of contraceptives (ORa = 0.4, 95% C.I. = 0.2-0.8); history of sexually transmitted diseases (ORa = 0.3, 95% C.I. = 0.1-0.8), and the principal informant about the Pap test, i.e., the health services personnel (ORa = 0.02, 95% C.I. = 0.0008-0.05). CONCLUSIONS: The lack of use and the misuse of Pap smears vary importantly among the different social and reproductive factors. But the principal reasons for lack of use were not knowing about the Pap test and a low educational level. We propose a greater diffusion on the benefits of the test in the Mexican population, through massive means of communication and health services.

[Classification by levels of clinico-epidemiological research designs]. / Clasificación en niveles de los diseños de investigación clínico-epidemiológicos.

The objective was to identify the characteristics of epidemiologic designs enabling their classification. A critical review of the literature in the clinical epidemiologic area was done to establish the main differences between designs. A meeting with experts to discuss this controversial topic and obtain criteria by consensus was organized. We propose an integral classification based on levels with two fundamental shafts: intervention and explanatory reasoning.

[Instrument to measure quality of life based on daily performance in pediatric patients with leukemia]. / Un instrumento para medir la calidad de vida por medio del desempeño diario en pacientes pediátricos con leucemia.

The objective of this study was to determine the validity of a questionnaire to measure daily performance as an evaluation of quality of life in pediatric leukemia patients. A questionnaire of the daily activities of a child according to Lickert's criteria was done. A pilot survey was performed in patients without a chronic or disabling disease in order to assess its validity. The impression of the medical attendance of each pediatric patient with leukemia, of their daily performance, was compared with the results of the instrument. A trained nurse applied the questionnaire to 60 mothers of patients (29 female/31 male) as outpatients during the clinical review. Fifteen questionnaires were applied twice to evaluate its consistency. According to the results, 77% of the patients were in remission. 15% in relapse, and 8% during induction to remission. The mean age of the patients was 9 = 3.6 years, ranging from 2-16 years. One hundred percent of the patients obtained a satisfactory grade greater than 35 points. In conclusion, the questionnaire identified adequately the level of the daily performance in addition to the specific affected areas of the patients with leukemia. Our findings are that their level of performance is satisfactory and is not affected because of the disease or the phase of the treatment.